Treatment of Dilated Cardiomyopathies with β-adrenergic Blocking Agents

Anti-adrenergic therapy with β-adrenergic blocking agents has proved to be effective in the medical treatment of various dilated cardiomyopathies, including idiopathic, valvular and ischemic subtypes. This report will summarize the effects of β-blocker treatment on the dilated cardiomyopathy phenotype, as well as on clinical parameters.